DouglasRichardLabrecqueMD

Hepatology & Liver Transplantation

Emeritus Professor of Medicine

Dr. Labrecque is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-1660

Fax+1 319-356-7918

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

35 citations
TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease.
Kejing Song, Ruth A. Coleman, Carol Alber, Zuhair K. Ballas, Thomas J. Waldschmidt
Alcohol. 2001-07-01
273 citations
World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Douglas R. LaBrecque, Zaigham Abbas, Frank Anania, Peter Ferenci, Aamir G. Khan
Journal of Clinical Gastroenterology. 2014-09-01
135 citations
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.
Peter Ferenci, Michael Fried, Douglas R. LaBrecque, Jordi Bruix, Morris Sherman
Journal of Gastrointestinal and Liver Diseases. 2010-09-01

Etiology Of Inherited Intrahepatic CholestasisNational Center For Research Resources1985–2002
Intron A Therapy For Treatment Of Relapse In Patients With Chronic Hepatitis CNational Center For Research Resources1997–1999
Intron A Monotherapy VS Intron A And Ribavirin For Chronic Hepatitis CNational Center For Research Resources1997–1999
Dirithromycin--Pharmacokinetics In Impaired Hepatic FunctionNational Center For Research Resources1992
Evaluation Of TrimethylaminuriaNational Center For Research Resources1990